U.K. Pharmaceuticals & Biotech Big Green Snowflakes

hVIVO

Market Cap: UK£53.1m

Operates as a pharmaceutical service and contract research company in the United Kingdom, Europe, and North America.

Hikma Pharmaceuticals

Market Cap: UK£3.8b

Develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products.

AstraZeneca

Market Cap: UK£172.2b

A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.

Animalcare Group

Market Cap: UK£162.8m

Develops, sells, and distributes licensed veterinary pharmaceuticals, and services for companion and production animals, and equine veterinary markets.

Bioventix

Market Cap: UK£128.0m

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide.

Physiomics

Market Cap: UK£1.3m

Provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland.

Genus

Market Cap: UK£1.6b

Operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia.

Haleon

Market Cap: UK£29.6b

Engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.

HUTCHMED (China)

Market Cap: UK£2.0b

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and internationally.

ECO Animal Health Group

Market Cap: UK£65.0m

ECO Animal Health Group plc, together with its subsidiaries, manufactured and supply animal health products internationally.

GSK

Market Cap: UK£63.4b

Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.

IXICO

Market Cap: UK£12.3m

Provides data analytics services to the biopharmaceutical industry in the United Kingdom, Switzerland, the Netherlands, Ireland, rest of Europe, and the United States.

Oxford Biomedica

Market Cap: UK£670.6m

A contract development and manufacturing organization, focuses on delivering therapies to patients worldwide.

Poolbeg Pharma

Market Cap: UK£25.1m

A clinical-stage biopharmaceutical company, focused on acquiring, developing, and commercialising of medicines for unmet medical needs in the United Kingdom.

Oxford BioDynamics

Market Cap: UK£9.3m

Operates as a biotechnology company that discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and the United Kingdom.

Shield Therapeutics

Market Cap: UK£78.0m

A commercial stage specialty pharmaceutical company, focuses on development and commercialization of clinical-stage pharmaceuticals to treat unmet medical needs.

Futura Medical

Market Cap: UK£11.6m

Research, develops, and commercializes pharmaceutical and healthcare products for sexual health.

Verici Dx

Market Cap: UK£10.2m

Together with its subsidiary, Verici Dx Inc, develops prognostic and diagnostic tests for kidney transplant patients in the United Kingdom and the United States.

Ovoca Bio

Market Cap: UK£938.0k

A clinical-stage biopharmaceutical company, develops and commercializes novel product candidates for women health.

BSF Enterprise

Market Cap: UK£4.2m

Develops and commercializes cutting-edge tissue-engineered solutions.

Theracryf

Market Cap: UK£4.6m

A clinical stage therapeutics company, engages in the development of therapeutics for oncology and behavioural brain disorders.

genedrive

Market Cap: UK£1.5m

Engages in the design, development, and manufacture of molecular diagnostics testing equipment for use in genotyping, pathogen detection, infectious disease detection, and other clinical indications.

Solvonis Therapeutics

Market Cap: UK£22.3m

A clinical-stage biopharmaceutical company, develops novel medicines for addiction and mental health disorders.

ProBiotix Health

Market Cap: UK£10.7m

Develops probiotics to tackle cardiovascular disease and other lifestyle conditions in the United Kingdom, the United States, and internationally.

Sareum Holdings

Market Cap: UK£36.6m

A clinical stage small molecule drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases.

Incanthera

Market Cap: UK£3.8m

A dermatology and oncology therapeutics company, focuses on the dermatological formulation and delivery technologies for various indications.

Nuformix

Market Cap: UK£4.7m

Together with its subsidiary, Nuformix Technologies Limited, operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom.

Diaceutics

Market Cap: UK£140.5m

A diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies.

SkinBioTherapeutics

Market Cap: UK£39.1m

A life science company, engages in research and development, and commercialization of technology that harnesses the microbiome for human health in the United Kingdom, the United States, Europe, and internationally.

Faron Pharmaceuticals Oy

Market Cap: UK£201.5m

Operates as a clinical stage drug discovery and development company.

Roquefort Therapeutics

Market Cap: UK£3.3m

A material biotech company, engages in the development of medicines for the treatment of cancer.

Aptamer Group

Market Cap: UK£20.2m

Provides binders for research, diagnostics, and therapeutics in the United Kingdom, rest of Europe, the United States, and internationally.

4basebio

Market Cap: UK£123.0m

Engages in the research, development, manufacturing, and commercialization of synthetic DNA and RNA products, and non-viral vector solutions in Europe, the United States, and internationally.

PureTech Health

Market Cap: UK£321.4m

Engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States.

ValiRx

Market Cap: UK£2.2m

A biopharmaceutical company, engages in the development of oncology therapeutics and companion diagnostics in the United Kingdom.

Fusion Antibodies

Market Cap: UK£19.9m

A contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally.